Virginia Retirement Systems Et Al Vertex Pharmaceuticals Inc Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 297,900 shares of VRTX stock, worth $138 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

297,900

Previous 297,900 -0.0%

Holding current value

$138 Million

Previous $105 Million 1.18%

% of portfolio

1.03%

Previous 1.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	BUY	$314.42 - $351.91 $1.23 Million - $1.37 Million	3,900 Added 1.33%	297,900 $105 Million
Q1 2023 Jul 11, 2023	BUY	$283.23 - $323.1 $6.74 Million - $7.69 Million	23,800 Added 8.81%	294,000 $92.6 Million
Q4 2022 May 17, 2023	SELL	$285.76 - $321.48 $1.23 Million - $1.38 Million	-4,300 Reduced 1.57%	270,200 $78 Billion
Q3 2022 May 16, 2023	SELL	$273.83 - $305.53 $2.82 Million - $3.15 Million	-10,300 Reduced 3.62%	274,500 $79.5 Billion
Q1 2022 Apr 21, 2022	SELL	$221.42 - $260.97 $3.56 Million - $4.2 Million	-16,100 Reduced 5.35%	284,800 $74.3 Million
Q4 2021 Feb 03, 2022	SELL	$177.01 - $223.45 $1.03 Million - $1.3 Million	-5,800 Reduced 1.89%	300,900 $66.1 Million
Q3 2021 Oct 21, 2021	BUY	$181.39 - $202.99 $3.61 Million - $4.04 Million	19,900 Added 6.94%	306,700 $55.6 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $93,745 - $110,550	-500 Reduced 0.17%	286,800 $57.8 Million
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $34.8 Million - $40.6 Million	168,100 Added 141.02%	287,300 $61.7 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $9.81 Million - $13.1 Million	47,400 Added 66.02%	119,200 $28.2 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $460,170 - $545,580	-1,800 Reduced 2.45%	71,800 $19.5 Million
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $22,548 - $29,580	-100 Reduced 0.14%	73,600 $21.4 Million
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $1.08 Million - $1.34 Million	5,400 Added 7.91%	73,700 $17.5 Million
Q4 2019 Jan 27, 2020	BUY	$166.71 - $223.91 $5.2 Million - $6.99 Million	31,200 Added 84.1%	68,300 $15 Million
Q3 2019 Oct 22, 2019	BUY	$166.23 - $187.09 $99,738 - $112,254	600 Added 1.64%	37,100 $6.29 Million
Q2 2019 Jul 26, 2019	BUY	$164.61 - $190.37 $6.01 Million - $6.95 Million	36,500 New	36,500 $6.69 Million
Q4 2018 Feb 07, 2019	SELL	$151.91 - $192.21 $531,685 - $672,735	-3,500 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$145.72 - $169.96 $510,020 - $594,860	3,500 New	3,500 $595,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Vertex Pharmaceuticals Inc Transaction History